{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:52:07Z","timestamp":1792252327441,"version":"4.4.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.det.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T20:57:47Z","timestamp":1637096267000},"page":"61-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Epidermal Nevi"],"prefix":"10.1016","volume":"40","author":[{"given":"Andrea R.","family":"Waldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Garzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly D.","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.det.2021.09.006_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ad.2018.05.005","article-title":"Epidermal nevi and related syndromes -- part 1: keratinocytic nevi","volume":"109","author":"Garcias-Ladaria","year":"2018","journal-title":"Actas Dermosifiliogr"},{"issue":"8","key":"10.1016\/j.det.2021.09.006_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.ad.2018.05.004","article-title":"Epidermal nevi and related syndromes -- part 2: nevi derived from adnexal structures","volume":"109","author":"Garcias-Ladaria","year":"2018","journal-title":"Actas Dermosifiliogr"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/pde.13273","article-title":"Epidermal nevus syndromes: new insights into whorls and swirls","volume":"35","author":"Asch","year":"2018","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.09.006_bib4","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/bjd.17924","article-title":"Mosaic abnormalities of the skin: review and guidelines from the European Reference Network for rare skin diseases","volume":"182","author":"Kinsler","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2021.09.006_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1365-2230.2005.01785.x","article-title":"Two squamous cell carcinomas arising in a linear epidermal nevus in a 28-year-old female","volume":"30","author":"Affleck","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.det.2021.09.006_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archderm.1981.01650040063028","article-title":"Basal cell epithelioma arising in a linear epidermal nevus","volume":"117","author":"Horn","year":"1981","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2021.09.006_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/DAD.0000000000000012","article-title":"Eccrine poroma and eccrine porocarcinoma in linear epidermal nevus","volume":"36","author":"Jeon","year":"2014","journal-title":"Am J Dermatopathol"},{"issue":"33","key":"10.1016\/j.det.2021.09.006_bib8","doi-asserted-by":"crossref","first-page":"13450","DOI":"10.1073\/pnas.0705218104","article-title":"Oncogenic PIK3Ca mutations occur in epidermal nevi and seborrheic keratoses with a characteristic mutation pattern","volume":"104","author":"Hafner","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.det.2021.09.006_bib9","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/sj.jid.5700772","article-title":"FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin","volume":"127","author":"Hafner","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib10","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1365-2133.2007.07869.x","article-title":"Fibroblast growth factor receptor 3 (FGFR3) mutation in a verrucous epidermal naevus associated with mild facial dysmorphism","volume":"156","author":"Collin","year":"2007","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib11","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1365-2133.2012.10812.x","article-title":"Identification of a novel S249C FGFR3 mutation in a keratinocytic epidermal naevus syndrome","volume":"167","author":"Ousager","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib12","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.jaad.2019.06.013","article-title":"Laser treatment of epidermal nevi: a multicenter retrospective study with long-term follow-up","volume":"83","author":"Alkhalifah","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2021.09.006_bib13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ad.2012.04.004","article-title":"Carbon dioxide laser treatment of epidermal nevi: response and long-term follow-up","volume":"103","author":"Alonso-Castro","year":"2012","journal-title":"Actas Dermosifiliogr"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jmedgenet-2011-100637","article-title":"Keratinocytic epidermal nevi are associated with mosaic RAS mutations","volume":"49","author":"Hafner","year":"2012","journal-title":"J\u00a0Med Genet"},{"issue":"8","key":"10.1016\/j.det.2021.09.006_bib15","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1016\/j.jid.2016.03.040","article-title":"Somatic embryonic FGFR2 mutations in keratinocytic epidermal nevi","volume":"136","author":"Toll","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/pde.13833","article-title":"Topical sirolimus therapy for epidermal nevus with features of acanthosis nigricans","volume":"36","author":"Dodds","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"21","key":"10.1016\/j.det.2021.09.006_bib17","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJM199411243312103","article-title":"Genetic and clinical mosaicism in a type of epidermal nevus","volume":"331","author":"Paller","year":"1994","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib18","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/pde.14529","article-title":"Epidermolytic epidermal nevus caused by a somatic mutation in KRT2","volume":"38","author":"Mohamad","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib19","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000247756","article-title":"Treatment of inflammatory linear verrucous epidermal nevus","volume":"182","author":"Rulo","year":"1991","journal-title":"Dermatologica"},{"issue":"9","key":"10.1016\/j.det.2021.09.006_bib20","first-page":"1141","article-title":"Treatment of inflammatory linear verrucous epidermal nevus pruritus with thalidomide","volume":"16","author":"Ossorio-Garc\u00eda","year":"2018","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000487001","article-title":"Successful treatment of inflammatory linear verrucous epidermal nevus with concomitant psoriasis using etanercept","volume":"10","author":"Saifaldeen","year":"2018","journal-title":"Case Rep Dermatol"},{"issue":"10","key":"10.1016\/j.det.2021.09.006_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5070\/D37TS7S0ST","article-title":"An inflammatory verrucous epidermal nevus concomitant with psoriasis: treatment with adalimumab","volume":"18","author":"\u00d6zdemir","year":"2012","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.det.2021.09.006_bib23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00000637-200109000-00011","article-title":"Full-thickness surgical excision for the treatment of inflammatory linear verrucous epidermal nevus","volume":"47","author":"Lee","year":"2001","journal-title":"Ann Plast Surg"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.5021\/ad.2020.32.6.534","article-title":"Successful amelioration of inflammatory linear verrucous epidermal nevus with topical sirolimus","volume":"32","author":"Patel","year":"2020","journal-title":"Ann Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.09.006_bib25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/pde.13793","article-title":"Inflammatory linear verrucous epidermal nevus treated successfully with crisaborole ointment in a 5-year-old boy","volume":"36","author":"Barney","year":"2019","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib26","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00000372-198204000-00011","article-title":"Histopathologic varieties of epidermal nevus. A study of 160 cases","volume":"4","author":"Su","year":"1982","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib27","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1046\/j.1523-1747.2000.00182.x","article-title":"Mosaicism for ATP2A2 mutations causes segmental Darier's disease","volume":"115","author":"Sakuntabhai","year":"2000","journal-title":"J\u00a0Invest Dermatol"},{"issue":"11","key":"10.1016\/j.det.2021.09.006_bib28","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jamadermatol.2015.1663","article-title":"Acantholytic dyskeratotic epidermal nevus","volume":"151","author":"Akinshemoyin Vaughn","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.det.2021.09.006_bib29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamadermatol.2018.5852","article-title":"A\u00a0somatic p.Phe29del mutation of connexin 26 (GJB2) manifesting as acantholytic dyskeratotic epidermal nevus","volume":"155","author":"Lee","year":"2019","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/(SICI)1096-8628(20000214)90:4<339::AID-AJMG15>3.0.CO;2-5","article-title":"Mutations in the NSDHL gene, encoding a 3beta-hydroxysteroid dehydrogenase, cause CHILD syndrome","volume":"90","author":"Konig","year":"2000","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib32","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1136\/jmg.2004.024448","article-title":"Mutational spectrum of NSDHL in CHILD syndrome","volume":"42","author":"Bornholdt","year":"2005","journal-title":"J\u00a0Med Genet"},{"issue":"11","key":"10.1016\/j.det.2021.09.006_bib33","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1038\/jid.2011.189","article-title":"Pathogenesis-based therapy reverses cutaneous abnormalities in an inherited disorder of distal cholesterol metabolism","volume":"131","author":"Paller","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1529-8019.2012.01528.x","article-title":"Pathogenesis-based therapies in ichthyoses","volume":"26","author":"Lai-Cheong","year":"2013","journal-title":"Dermatol Ther"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib35","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1684\/ejd.2011.1549","article-title":"Topical treatment of CHILD nevus and Sjogren-Larsson Syndrome with combined lovastatin and cholesterol","volume":"21","author":"Merino De Paz","year":"2011","journal-title":"Eur J Dermatol"},{"issue":"11","key":"10.1016\/j.det.2021.09.006_bib36","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/sj.ejhg.5201638","article-title":"The challenges of Proteus syndrome: diagnosis and management","volume":"14","author":"Biesecker","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.det.2021.09.006_bib37","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1104017","article-title":"A\u00a0mosaic activating mutation in AKT1 associated with the Proteus syndrome","volume":"365","author":"Lindhurst","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1399-0004.2011.01807.x","article-title":"Origins of the elephant man: mosaic somatic mutations cause Proteus syndrome","volume":"81","author":"De Souza","year":"2012","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib39","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/0363-5023(92)90109-3","article-title":"Proteus syndrome","volume":"17","author":"Barmakian","year":"1992","journal-title":"J\u00a0Hand Surg Am"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib40","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ajmg.c.31531","article-title":"Somatic overgrowth disorders of the PI3K\/AKT\/mTOR pathway & therapeutic strategies","volume":"172","author":"Keppler-Noreuil","year":"2016","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.1311","article-title":"Causes of premature death in Proteus syndrome","volume":"101","author":"Cohen","year":"2001","journal-title":"Am J Med Genet"},{"issue":"8","key":"10.1016\/j.det.2021.09.006_bib42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/archderm.140.8.947","article-title":"Cutaneous manifestations of proteus syndrome: correlations with general clinical severity","volume":"140","author":"Nguyen","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.det.2021.09.006_bib43","series-title":"GeneReviews\u00ae [Internet]","article-title":"Proteus syndrome","author":"Biesecker","year":"2012"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib44","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/ajmg.c.31735","article-title":"Thrombosis risk factors in PIK3CA-related overgrowth spectrum and Proteus syndrome","volume":"181","author":"Keppler-Noreuil","year":"2019","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"3","key":"10.1016\/j.det.2021.09.006_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/bjd.14478","article-title":"Extending the spectrum of AKT1 mosaicism: not just the Proteus syndrome","volume":"175","author":"Polubothu","year":"2016","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13023-021-01745-0","article-title":"Clinical experience with the AKT1 inhibitor miransertib in two children with PIK3CA-related overgrowth syndrome","volume":"16","author":"Forde","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib47","first-page":"133","article-title":"Linear Cowden nevus: a new distinct epidermal nevus","volume":"17","author":"Happle","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.det.2021.09.006_bib48","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1146\/annurev-med-052218-125823","article-title":"The clinical spectrum of PTEN mutations","volume":"71","author":"Yehia","year":"2020","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib49","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajmg.a.36836","article-title":"PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation","volume":"167A","author":"Keppler-Noreuil","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"24","key":"10.1016\/j.det.2021.09.006_bib50","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1002\/ajmg.a.32023","article-title":"Newly delineated syndrome of congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE syndrome) in seven patients","volume":"143A","author":"Sapp","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"20","key":"10.1016\/j.det.2021.09.006_bib51","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/ajmg.a.32515","article-title":"Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi (CLOVE) syndrome: CNS malformations and seizures may be a component of this disorder","volume":"146A","author":"Gucev","year":"2008","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib52","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MOP.0000000000000923","article-title":"PIK3CA vascular overgrowth syndromes: an update","volume":"32","author":"Hughes","year":"2020","journal-title":"Curr Opin Pediatr"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib53","first-page":"662","article-title":"CLOVES syndrome: treatment with oral Rapamycin. Report of two cases","volume":"90","author":"Renatta de Grazia","year":"2019","journal-title":"Rev Chil Pediatr"},{"issue":"7711","key":"10.1016\/j.det.2021.09.006_bib54","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-018-0217-9","article-title":"Targeted therapy in patients with PIK3CA-related overgrowth syndrome","volume":"558","author":"Venot","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.det.2021.09.006_bib55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archneur.1969.00480150032003","article-title":"Two unusual neurocutaneous disorders with facial cutaneous signs","volume":"21","author":"Sugarman","year":"1969","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib56","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddt429","article-title":"Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia","volume":"23","author":"Lim","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajmg.a.30915","article-title":"Skeletal changes in epidermal nevus syndrome: does focal bone disease harbor clues concerning pathogenesis?","volume":"139A","author":"Heike","year":"2005","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib58","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4103\/ijem.IJEM_3_20","article-title":"Epidermal nevus syndrome with hypophosphatemic rickets","volume":"24","author":"Goyal","year":"2020","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.det.2021.09.006_bib59","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0022-3476(77)80444-7","article-title":"Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions","volume":"91","author":"Aschinberg","year":"1977","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00223-020-00705-3","article-title":"New therapies for hypophosphatemia-related to FGF23 excess","volume":"108","author":"Athonvarangkul","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.det.2021.09.006_bib61","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/archderm.1965.01600120006002","article-title":"Life history of organoid nevi. Special reference to nevus sebaceus of Jadassohn","volume":"91","author":"Mehregan","year":"1965","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib62","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/modpathol.3880346","article-title":"The role of androgen receptors in the clinical course of nevus sebaceus of Jadassohn","volume":"14","author":"Hamilton","year":"2001","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.det.2021.09.006_bib63","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ng.2316","article-title":"Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome","volume":"44","author":"Groesser","year":"2012","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.det.2021.09.006_bib64","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/jid.2012.379","article-title":"Whole-exome sequencing reveals somatic mutations in HRAS and KRAS, which cause nevus sebaceus","volume":"133","author":"Levinsohn","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ced.12209","article-title":"Naevus sebaceus: a mosaic RASopathy","volume":"39","author":"Aslam","year":"2014","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/bjd.14681","article-title":"Mosaic-activating FGFR2 mutation in two fetuses with papillomatous pedunculated sebaceous naevus","volume":"176","author":"Kuentz","year":"2017","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib67","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/bjd.15042","article-title":"Mosaicism in the skin: lumping or splitting?","volume":"176","author":"Has","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2021.09.006_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17319","article-title":"Cerebriform sebaceous nevus: a subtype of organoid nevus due to specific postzygotic FGFR2 mutations","author":"Theiler","year":"2021","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/ijd.12845","article-title":"Nevus sebaceus: a clinicopathological study of 168 cases and review of the literature","volume":"55","author":"Kamyab-Hesari","year":"2016","journal-title":"Int J Dermatol"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib70","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jaad.2013.10.004","article-title":"Secondary neoplasms associated with nevus sebaceus of Jadassohn: a study of 707 cases","volume":"70","author":"Idriss","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.09.006_bib71","series-title":"Consensus Statement on the use of Anesthetic and sedative drugs in infants and toddlers","year":"2015"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib72","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.spen.2015.10.001","article-title":"Nevus sebaceous and its association with neurologic involvement","volume":"22","author":"Rizzo","year":"2015","journal-title":"Semin Pediatr Neurol"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib73","doi-asserted-by":"crossref","first-page":"441","DOI":"10.14348\/molcells.2019.0037","article-title":"Neurodevelopmental aspects of RASopathies","volume":"42","author":"Kim","year":"2019","journal-title":"Mol Cells"},{"issue":"5","key":"10.1016\/j.det.2021.09.006_bib74","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00467-011-2086-4","article-title":"Linear nevus sebaceous syndrome with hypophosphatemic rickets with elevated FGF-23","volume":"27","author":"Narazaki","year":"2012","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"10.1016\/j.det.2021.09.006_bib75","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/ajmg.a.37135","article-title":"A\u00a0postzygotic NRAS mutation in a patient with Schimmelpenning syndrome","volume":"167A","author":"Kuroda","year":"2015","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib76","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/(SICI)1096-8628(19961111)65:4<363::AID-AJMG27>3.0.CO;2-R","article-title":"Phacomatosis pigmentokeratotica: a melanocytic-epidermal twin nevus syndrome","volume":"65","author":"Happle","year":"1996","journal-title":"Am J Med Genet"},{"issue":"15","key":"10.1016\/j.det.2021.09.006_bib77","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1056\/NEJMicm1817155","article-title":"Phakomatosis Pigmentokeratotica","volume":"381","author":"Kubo","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.det.2021.09.006_bib78","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/ced.12961","article-title":"HRAS mutation in phacomatosis pigmentokeratotica without extracutaneous disease","volume":"42","author":"Jennings","year":"2017","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.09.006_bib79","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/pde.13119","article-title":"Phacomatosis Pigmentokeratotica: a mosaic RASopathy with malignant potential","volume":"34","author":"Om","year":"2017","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib80","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/bjd.15643","article-title":"Phacomatosis pigmentokeratotica and precocious puberty associated with HRAS mutation","volume":"178","author":"Martin","year":"2018","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2021.09.006_bib81","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jid.2016.01.015","article-title":"Postzygotic BRAF p.Lys601Asn mutation in phacomatosis pigmentokeratotica with woolly hair nevus and focal cortical dysplasia","volume":"136","author":"Kuentz","year":"2016","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2133.2006.07313.x","article-title":"Phacomatosis pigmentokeratotica associated with hypophosphataemic rickets, pheochromocytoma and multiple basal cell carcinomas","volume":"155","author":"Bouthors","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2021.09.006_bib83","article-title":"Phacomatosis spilosebacea: a new name for a distinctive binary genodermatosis","author":"Torchia","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib84","doi-asserted-by":"crossref","first-page":"1060.e1-4","DOI":"10.1016\/j.jaad.2009.03.036","article-title":"Widespread porokeratotic adnexal ostial nevus: clinical features and proposal of a new name unifying porokeratotic eccrine ostial and dermal duct nevus and porokeratotic eccrine and hair follicle nevus","volume":"61","author":"Goddard","year":"2009","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"10","key":"10.1016\/j.det.2021.09.006_bib85","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1111\/jdv.12732","article-title":"Porokeratotic adnexal ostial naevus: review on the entity and therapeutic approach","volume":"29","author":"Llamas-Velasco","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib86","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1111\/pde.12458","article-title":"A\u00a0unique association of unilateral idiopathic calcinosis cutis with ipsilateral porokeratotic eccrine ostial and dermal duct nevus","volume":"32","author":"Vasudevan","year":"2015","journal-title":"Pediatr Dermatol"},{"issue":"2 Suppl 1","key":"10.1016\/j.det.2021.09.006_bib87","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jaad.2007.09.034","article-title":"Generalized porokeratotic eccrine ostial and dermal duct nevus associated with deafness","volume":"59","author":"Jamora","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.det.2021.09.006_bib88","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1038\/jid.2012.143","article-title":"Porokeratotic eccrine nevus may be caused by somatic connexin26 mutations","volume":"132","author":"Easton","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.09.006_bib89","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1525-1470.2011.01425.x","article-title":"Extending the phenotypic spectrum of keratitis-ichthyosis-deafness syndrome: report of a patient with GJB2 (G12R) Connexin 26 mutation and unusual clinical findings","volume":"29","author":"Lazic","year":"2012","journal-title":"Pediatr Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.09.006_bib90","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jdermsci.2015.07.003","article-title":"Porokeratotic eccrine ostial and dermal duct nevus with a somatic homozygous or monoallelic variant of connexin 26","volume":"80","author":"Noda","year":"2015","journal-title":"J\u00a0Dermatol Sci"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib91","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/jamadermatol.2014.5069","article-title":"A\u00a0Somatic p.G45E GJB2 mutation causing porokeratotic eccrine ostial and dermal duct nevus","volume":"151","author":"Levinsohn","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib92","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1525-1470.1991.tb00938.x","article-title":"Nevus comedonicus: case report and brief review of the literature","volume":"8","author":"Cestari","year":"1991","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib93","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-4632.2004.02188.x","article-title":"Extensive inflammatory nevus comedonicus involving half of the body","volume":"43","author":"Kirtak","year":"2004","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib94","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/DAD.0000000000001317","article-title":"Late-onset nevus comedonicus with follicular epidermolytic hyperkeratosis-case report and review of the literature","volume":"41","author":"Zanniello","year":"2019","journal-title":"Am J Dermatopathol"},{"issue":"9129","key":"10.1016\/j.det.2021.09.006_bib95","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0140-6736(05)60820-3","article-title":"Epidermal mosaicism producing localised acne: somatic mutation in FGFR2","volume":"352","author":"Munro","year":"1998","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.det.2021.09.006_bib96","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/j.ajhg.2016.03.019","article-title":"Somatic Mutations in NEK9 Cause Nevus Comedonicus","volume":"98","author":"Levinsohn","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.det.2021.09.006_bib97","article-title":"Three novel pathogenic NEK9 variants in patients with nevus comedonicus: a case series","author":"Juratli","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib98","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/ajmg.a.61490","article-title":"Further delineation of the phenotypic spectrum of nevus comedonicus syndrome to include congenital pulmonary airway malformation of the lung and aneurysm","volume":"182","author":"Sheppard","year":"2020","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.det.2021.09.006_bib99","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/pde.14508","article-title":"Nevus comedonicus syndrome: a systematic review of the literature","volume":"38","author":"Torchia","year":"2021","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.det.2021.09.006_bib100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1067\/mjd.2003.182","article-title":"Prevalence of Becker's nevi in a population of young men in central Italy","volume":"48","author":"Ballone","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2021.09.006_bib101","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1525-1470.2012.01734.x","article-title":"Clinical characteristics of Becker's nevus in children: report of 118 cases from Italy","volume":"29","author":"Patrizi","year":"2012","journal-title":"Pediatr Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib102","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/000155598442034","article-title":"Becker's naevus occurring at birth and in early childhood","volume":"78","author":"Sood","year":"1998","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.det.2021.09.006_bib103","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jaad.2008.06.028","article-title":"Androgen receptor expression patterns in Becker's nevi: an immunohistochemical study","volume":"59","author":"Grande Sarpa","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.09.006_bib104","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/14764172.2015.1114647","article-title":"The use of lasers in Becker's naevus: an evidence-based review","volume":"18","author":"Momen","year":"2016","journal-title":"J\u00a0Cosmet Laser Ther"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib105","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s10103-019-02734-3","article-title":"Lasers for Becker's nevus","volume":"34","author":"Zhong","year":"2019","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.det.2021.09.006_bib106","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<357::AID-AJMG20>3.0.CO;2-R","article-title":"Becker nevus syndrome","volume":"68","author":"Happle","year":"1997","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.det.2021.09.006_bib107","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jaad.2004.06.036","article-title":"Becker\u2019s nevus syndrome revisited","volume":"51","author":"Danarti","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.09.006_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2021.03.095","article-title":"Becker nevus syndrome: a 2020 update","author":"Torchia","year":"2021","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.det.2021.09.006_bib109","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.jid.2017.03.017","article-title":"Postzygotic mutations in beta-actin are associated with Becker's nevus and Becker's nevus syndrome","volume":"137","author":"Cai","year":"2017","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.det.2021.09.006_bib110","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/cup.13683","article-title":"Post-zygotic ACTB mutations underlie congenital smooth muscle hamartomas","volume":"47","author":"Atzmony","year":"2020","journal-title":"J\u00a0Cutan Pathol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863521000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863521000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:45:03Z","timestamp":1760006703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863521000735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":109,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0733863521000735"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2021.09.006","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidermal Nevi","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}